Status:
COMPLETED
Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 Pneumonia
Lead Sponsor:
Sisli Hamidiye Etfal Training and Research Hospital
Conditions:
Corona Virus Infection
Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
In this study, the investigator examined epidemiological and demographic characteristics, risk factors and 28-day mortality of patients admitted to the intensive care unit with the diagnosis of corona...
Detailed Description
The patients with intensive care requirements were admitted from emergency department and coronavirus disease 2019 wards to our units. The criteria for intensive care requirement was identified as oxy...
Eligibility Criteria
Inclusion
- The study was planned retrospectively, cross-sectionally and observationally with 193 patients hospitalized between 16 March 2020 and 15 May 2020 in five different coronavirus disease 2019 intensive care units in two campuses of our hospital.
Exclusion
- Health workers, patients hospitalized less than 24 hours, patients with negative polymerase chain reaction tests, and patients who returned to intensive care unit after discharge were excluded from the study.
Key Trial Info
Start Date :
May 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 5 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04430023
Start Date
May 15 2020
End Date
June 5 2020
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sisli Etfal Research and Training Hospital
Istanbul, Marmara, Turkey (Türkiye), 34371